Excelera DCE and special purpose acquisition company Future Health ESG Corp.
on Tuesday said they entered a business combination deal that will see Excelera become a publicly traded company.
Excelera said it “equips physicians with precision medicine insights and financial resources to succeed in Medicare’s value-based delivery programs.”
The deal values Excelera at $459 million, the companies said, adding it is expected to provide up to $282 million to accelerate expansion of Excelera’s network. Once the deal is completed, the combined company, which will be renamed Excelera Health, Inc., is expected to be listed on the Nasdaq under the ticker symbol XLRA.
The companies said both boards have unanimously approved the deal.
The companies said Excelera will continue to be led by its existing management team once the deal closes.